Get the Stockscreener App
0.207
0.96%
-0.002
After Hours:
.21
0.003
+1.45%
Virax Biolabs Group Ltd stock is traded at $0.207, with a volume of 140.01K.
It is down -0.96% in the last 24 hours and down -6.80% over the past month.
Virax Biolabs Group Ltd is an inventive biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Through its ViraxImmune platform and ImmuneSelect portfolio of research-use-only (RUO) products and services, the Company is building an immune-profiling offering that spans RUO assays, preclinical immunology services and, longer term, T cell-based diagnostics aimed at post-acute infection syndromes (PAIS) such as Long COVID and other chronic conditions linked to immune dysregulation.
See More
Previous Close:
$0.209
Open:
$0.209
24h Volume:
140.01K
Relative Volume:
0.03
Market Cap:
$1.54M
Revenue:
$79,300
Net Income/Loss:
$-6.92M
P/E Ratio:
-0.0109
EPS:
-18.9818
Net Cash Flow:
$-5.34M
1W Performance:
-6.33%
1M Performance:
-6.80%
6M Performance:
-63.36%
1Y Performance:
-84.78%
1-Day Range:
$0.207
$0.22
1-Week Range:
$0.1916
$0.235
52-Week Range:
$0.1916
$1.58
Virax Biolabs Group Ltd Stock (VRAX) Company Profile
Name
Virax Biolabs Group Ltd
Sector
Industry
Phone
-
Address
-
Compare VRAX vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VRAX
Virax Biolabs Group Ltd
|
0.207 | 1.55M | 79,300 | -6.92M | -5.34M | -18.98 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.11 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Virax Biolabs Group Ltd Stock (VRAX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-31-25 | Initiated | H.C. Wainwright | Buy |
Virax Biolabs Group Ltd Stock (VRAX) Latest News
00019 Should I Buy - Intellectia AI
PRH Should I Buy - Intellectia AI
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
Virax Biolabs Group Limited (NASDAQ:VRAX) Short Interest Down 67.6% in February - Defense World
ONEG.O Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
MGR Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
US Market Recap: Will Virax Biolabs Group Limited benefit from sector rotationJuly 2025 Intraday Action & Community Shared Stock Ideas - baoquankhu1.vn
Volume Summary: How much upside does HSDT haveWeekly Market Outlook & Free Accurate Trade Setup Notifications - baoquankhu1.vn
TCGL Should I Buy - Intellectia AI
Day Trade: Is now the right time to enter AEISWeekly Trend Recap & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
SKX PE Ratio & Valuation, Is SKX Overvalued - Intellectia AI
VRAX PE Ratio & Valuation, Is VRAX Overvalued - Intellectia AI
Analysts Offer Insights on Healthcare Companies: RegenXBio (RGNX) and Nektar Therapeutics (NKTR) - The Globe and Mail
IVF Should I Buy - Intellectia AI
Exit Recap: Is Oriental Culture Holding LTD stock risky to hold nowEarnings Summary Report & Short-Term High Return Ideas - baoquankhu1.vn
Virax Biolabs Sets March 11, 2026 AGM to Vote on Reverse Share Split and New Equity Plan - The Globe and Mail
Bull Bear: Does Virax Biolabs Group Limited offer margin of safetyMarket Activity Report & Safe Entry Momentum Stock Tips - baoquankhu1.vn
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Exit Recap: Should I average down on PodcastOne Inc stockGap Down & Smart Investment Allocation Insights - baoquankhu1.vn
Virax Biolabs Group Limited (NASDAQ:VRAX) Short Interest Update - Defense World
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Virax Biolabs Group (NASDAQ:VRAX) Upgraded at Zacks Research - Defense World
Virax Biolabs Group Limited (VRAX) Upgraded to Buy: Here's Why - Yahoo Finance
Virax Biolabs stock price target lowered to $1 at H.C. Wainwright By Investing.com - Investing.com South Africa
Virax Biolabs stock price target lowered to $1 at H.C. Wainwright - Investing.com India
Virax Biolabs secures $5 million in private placement to advance immunology research - MSN
HC Wainwright Reaffirms “Buy” Rating for Virax Biolabs Group (NASDAQ:VRAX) - Defense World
Virax Biolabs: Clinical Progress in PAIS and Extended Cash Runway Support Reiterated Buy Rating Despite Lowered Price Target - TipRanks
VRAX Analyst Forecasts - Quiver Quantitative
Why Virax Biolabs Group Limited stock is favored by top institutions - Улправда
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Wondering what's happening in today's after-hours session? - Chartmill
Virax Biolabs Releases Interim Financial Results for September 2025 - The Globe and Mail
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Is Virax Biolabs Group Limited stock positioned for long term growthJuly 2025 Update & Real-Time Market Trend Scan - Улправда
Can Virax Biolabs Group Limited stock beat market expectations this quarterWeekly Market Outlook & Real-Time Sentiment Analysis - Улправда
Virax Biolabs (NASDAQ: VRAX) details 25.9M-share resale from $5M raise - Stock Titan
Virax Biolabs Group (NASDAQ:VRAX) Shares Down 11.3% – Here’s Why - Defense World
A new trading data show Virax Biolabs Group Ltd (VRAX) is showing positive returns. - Setenews
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Penny Stocks To Keep An Eye OnDecember 3rd - MarketBeat
Why Virax Biolabs Group Limited stock is seen as undervalued2025 Geopolitical Influence & Detailed Earnings Play Alerts - Newser
Virax Biolabs Secures $5 Million in Private Placement to Advance Immunology Research - The Globe and Mail
Virax Biolabs (Nasdaq: VRAX) closes $5 million raise, cash runway into 2028 - Stock Titan
US Market Preview | VRAX Surges 108.0%; ADP Jobs Data Misses Expectations, Futures Rise; NVDA's OpenAI Investment Pending - Sahm
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Healthy Upside Potential: Transocean Ltd (RIG) - Setenews
Ready to Jump After Recent Trade: Virax Biolabs Group Ltd (VRAX) - setenews.com
Why UiPath Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket - Benzinga
Virax Biolabs (VRAX) Stock Cools After Hours Following 75% Rally - Benzinga
Virax Biolabs Group Ltd Stock (VRAX) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.69%
0.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):